I have stumbled upon this study on Various brands of Thyroxine. The goal was to test variable potency and equivalency.
I am having a good result with Sandoz brand T3. It has been a huge improvement from the Mercury brand. I am also on a 50mcg dose of Actavis brand Levothyroxine. It is a bit pointless it was removed at one point and I felt no different. I suspect the endo finds it easier to justify a combo therapy than just T3.
I was wanting to try switching to Sandoz Levo to see if I get a similar good result to my Liothyronine.
This report says Sandoz Levo was 12% more bioavailable. Very interesting!
academic.oup.com/jcem/artic...
#Hypothroidism #Levothyroxine #Thyroxine #T4 #T3